Search for: "Kahn v. Price" Results 21 - 40 of 92
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
5 Jul 2020, 5:09 am
Class V Stockholders Litigation, [1] finding that the complaint alleged facts that made it “reasonably conceivable” that the safe harbor established by Kahn v. [read post]
27 Feb 2020, 5:45 am by John Jascob
Thereafter, a majority of unaffiliated AmTrust stockholders approved the amended merger proposal.The plaintiffs filed a complaint alleging that the final transaction did not comply with the framework set forth in Kahn v. [read post]
16 Jan 2020, 3:20 pm by Francis Pileggi
  The High Court determined that the requirement was not satisfied based on the facts of the instant case because the “economic bargaining took place prior to the date” when the protections announced in the Kahn v. [read post]
16 Sep 2019, 7:05 pm by Carl Neff
  Plaintiff asserted the buyer was GGP’s de facto controlling shareholder, and that the procedural protections required pursuant to Kahn v. [read post]
18 Jun 2019, 6:42 am by Francis Pileggi
Apr. 16, 2019), the Court reversed the Court of Chancery’s holding that “unaffected market price” was the fair value on the date of the merger. [read post]
27 Mar 2019, 1:00 am by Thaddeus Mason Pope, JD, PhD
Pharmaceutical Pricing Jaime King, University of California Hastings College of the Law, The Burden of Federalism: Challenges to State Attempts at Controlling Prescription Drug Costs Marc Rodwin, Suffolk University Law School, Controlling Pharmaceutical Prices: What the U.S. [read post]
14 Oct 2017, 5:05 am by Garrett Hinck
Matthew Kahn posted a press release from the chief defense counsel for the military commissions announcing that he had disbanded the civilian defense team in U.S. v. [read post]
27 Apr 2017, 1:30 am by Thaddeus Mason Pope, JD, PhD
Kline School of Law, Taming Pharma with Benefit CorporationsDmitry Karshtedt, The George Washington University Law School, Regulating ‘Evergreening’: The FDA's Role in the Creation of Balanced Rights for Pharmaceutical ImprovementsMichael Sinha, Brigham and Women's Hospital and Harvard Medical School, Legal Approaches to Ensuring Timely Generic Drug AvailabilityRebecca Wolitz, Stanford Law School, Patents, Preemption, and Price-Gouging Teaching Session 1G – Room… [read post]
1 Nov 2016, 9:00 am by Albert H. Manwaring, IV
To obtain the most deferential judicial review, business judgment, in a challenge to a squeeze-out merger, the controlling stockholder may, however, structure the merger to satisfy the MFW framework approved by the Delaware Supreme Court in Kahn v. [read post]
26 Aug 2016, 6:21 am
He connected with individuals around the world whom he knew only by screen names such as `Moody Blues’ or “Aly Kahn,” or by email addresses. [read post]